Physician profile
Dean E Davis
NPI 1952371601
$821.34
in general payments reported to CMS, 2019-2025
14 companies · $60.75 in 2025
The $60.75 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $142 · 2021: $61.68 · 2022: $117 · 2023: $163 · 2024: $92.01 · 2025: $60.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $218.73 | 2019-2025 | Veozah |
| Pfizer INC. | $105.48 | 2019-2024 | |
| Abbvie INC. | $105.02 | 2019-2022 | |
| Roche Diagnostics Corporation | $89.55 | 2019-2020 | |
| Therapeuticsmd, INC. | $73.74 | 2019-2021 | |
| Daiichi Sankyo INC. | $49.89 | 2022 | |
| Inari Medical, INC. | $44.42 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $42.25 | 2022-2023 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $25.25 | 2021-2022 | |
| Osiris Therapeutics INC. | $17.31 | 2019 | |
| Scynexis, INC. | $14.60 | 2022 | |
| Minerva Surgical, INC | $13.09 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.02 | 2019 | |
| Hologic Sales and Service, LLC | $10.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.